Literature DB >> 7174851

Direct evidence of localised immunological damage in vulvar lichen sclerosus et atrophicus.

R J Dickie, C H Horne, H W Sutherland, P D Bewsher, L Stankler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7174851      PMCID： PMC497990          DOI： 10.1136/jcp.35.12.1395-c

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  3 in total

1.  The association between lichen sclerosus et atrophicus and HLA-B40.

Authors:  C I Harrington; K Gelsthorpe
Journal:  Br J Dermatol       Date:  1981-05       Impact factor: 9.302

2.  Organ-specific antibodies in patients with lichen sclerosus.

Authors:  S K Goolamali; E W Barnes; W J Irvine; S Shuster
Journal:  Br Med J       Date:  1974-10-12

3.  An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus.

Authors:  C I Harrington; I R Dunsmore
Journal:  Br J Dermatol       Date:  1981-05       Impact factor: 9.302
  3 in total
  4 in total

1.  Lichen sclerosus of the oral cavity. Case report and review of literature.

Authors:  Herald Justin Sherlin; Karthikeyan Ramalingam; Anuja Natesan; Pratibha Ramani; Priya Premkumar; Chandrasekar Thiruvenkadam
Journal:  J Dermatol Case Rep       Date:  2010-12-19

2.  Balanitis xerotica obliterans: An observational, descriptive and retrospective clinical study.

Authors:  Gyula László Fekete; Dominik Schwarzkopf-Kolb; Ilarie Brihan; Daniel Boda; László Fekete
Journal:  Exp Ther Med       Date:  2022-03-31       Impact factor: 2.447

3.  Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus.

Authors:  F E Clay; M J Cork; J K Tarlow; A I Blakemore; C I Harrington; F Lewis; G W Duff
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

4.  A case of lichen sclerosus et atrophicus accompanying bullous morphea.

Authors:  Sirin Yasar; Ceyda Tanzer Mumcuoglu; Zehra Asiran Serdar; Pembegul Gunes
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.